Document Type

Article

Publication Date

6-2-2022

DOI

10.1001/jamahealthforum.2022.2197

Abstract

Even before COVID-19 emerged in Wuhan, China, in December 2019, the prevailing global narrative was inequity—in health, income, race, and socioeconomic status. COVID-19 amplified all these inequities. Early in the pandemic, low-income countries were left without key medical resources, such as diagnostic tests, personal protective equipment, and ventilators. By 2021, inequitable vaccine distribution captured global attention and outrage. This year, high-income countries have bought the lion’s share of Paxlovid, a highly effective antiviral treatment. Vaccine inequities remain with only 16% of people in low-income countries having received at least 1 vaccine dose vs 80% of people across high-income countries. This article provides a roadmap to a new global health architecture with health equity at the center.

Publication Citation

JAMA Health Forum, 2022;3(6):e222197.

Share

COinS